Spinal Muscular Atrophy Trial, Recruiting NCT07712198 Sponsor: Trabzon Kanuni Education and Research Hospital Condition: Spinal Muscular Atrophy
Back to Spinal Muscular Atrophy

Spinal Muscular Atrophy Trial, Recruiting

NCT07712198
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old
  • People who have been admitted to an intensive care unit because of a brain-related condition, such as bleeding in or around the brain, a brain tumour, or a stroke
  • People (or their legal representative) who have given formal written agreement to take part in the trial

Who may not be able to join:

  • People who are under 18 or over 65 years old
  • People who have not been able to meet recommended nutrition and feeding targets set by standard European clinical guidelines (confirm with trial site)
  • People who are receiving palliative care or home-based care
  • People with a very high body weight, specifically a BMI of 40 or above
  • People with a history of a disease that affects the muscles or nerves
  • People who have had an amputation of part or all of a leg
  • People who have previously had an injury affecting the thigh area
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905369549350

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Trabzon Kanuni Education and Research Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2026
Est. completion
30 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Accuracy of Artificial Intelligence Models in Predicting Day-7 Sarcopenia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov